Advisor Group Holdings »

Aprea Therapeutics shares owned by Advisor Group Holdings

Quarter-by-quarter ownership of Aprea Therapeutics (APRE) shares owned by Advisor Group Holdings from 13F filings

Historical chart of Advisor Group Holdings investment in Aprea Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aprea Therapeutics held by Advisor Group Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aprea Therapeutics by Advisor Group Holdings

Quarter filed Position value Share count Share price at filing
2023-12-31 $940 200 4.70
2023-09-30 $833 200 4.17
2023-06-30 $630 200 3.15
2023-03-31 $888 200 4.44

More positions owned by Advisor Group Holdings

Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
NVIDIA Corporation (NVDA)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core Total Usd (IUSB)
Spdr Ser Tr Portfolio S&p500 (SPLG)

View all positions for Advisor Group Holdings

Top funds holding Aprea Therapeutics

AIGH Capital Management
Worth Venture Partners
Walleye Trading Advisors
Royal Bank of Canada
Vanguard Group
Bank of America Corporation
Pnc Financial Services
Wells Fargo & Company
Advisor Group Holdings
WealthCollab
Jpmorgan Chase & Co
UBS Group

View all funds holding Aprea Therapeutics